Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2010, Article ID 362847, 9 pages
http://dx.doi.org/10.1155/2010/362847
Review Article

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease

1Department of Gastroenterology and Neurology, Akita University Graduate School of Medicine, 1-1-1 Hondo Akita-shi, Akita 010-8543, Japan
2Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA

Received 11 April 2010; Revised 28 October 2010; Accepted 15 December 2010

Academic Editor: Ian Nicholas Crispe

Copyright © 2010 Kouichi Miura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [89 citations]

The following is the list of published articles that have cited the current article.

  • Dorothy D. Sears, and Jane J. Kim, “TLR4 and insulin resistance,” Gastroenterology Research and Practice, 2010. View at Publisher · View at Google Scholar
  • L Li, L Chen, and L Hu, “Nuclear Factor High-mobility Group Box1 Mediating the Activation of Toll-like Receptor 4 Signaling in Hepatocytes in the Early Stage of Non-alcoholic Fatty Liver Disease in Mice,” Journal of Clinical and Experimental Hepatology, vol. 1, no. 2, pp. 123–124, 2011. View at Publisher · View at Google Scholar
  • Andrea De Gottardi, and Kathy D. McCoy, “Evaluation of the gut barrier to intestinal bacteria in non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 55, no. 6, pp. 1181–1183, 2011. View at Publisher · View at Google Scholar
  • Patrice D. Cani, Melania Osto, Lucie Geurts, and Amandine Everard, “Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity,” Gut Microbes, vol. 3, no. 4, 2012. View at Publisher · View at Google Scholar
  • D. Compare, P. Coccoli, A. Rocco, O.M. Nardone, S. De Maria, M. Cartenì, and G. Nardone, “Gut–liver axis: The impact of gut microbiota on non alcoholic fatty liver disease,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 22, no. 6, pp. 471–476, 2012. View at Publisher · View at Google Scholar
  • Kouichi Miura, Ling Yang, Nico van Rooijen, Hirohide Ohnishi, and Ekihiro Seki, “Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2,” American Journal Of Physiology-Gastrointestinal And Liver Physiology, vol. 302, no. 11, pp. G1310–G1321, 2012. View at Publisher · View at Google Scholar
  • Christian L. Roth, Clinton T. Elfers, Dianne P. Figlewicz, Susan J. Melhorn, Gregory J. Morton, Andrew Hoofnagle, Matthew M. Yeh, James E. Nelson, and Kris V. Kowdley, “Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and toll-like receptor activation,” Hepatology, vol. 55, no. 4, pp. 1103–1111, 2012. View at Publisher · View at Google Scholar
  • Ekihiro Seki, and Bernd Schnabl, “Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut,” Journal Of Physiology-London, vol. 590, no. 3, pp. 447–458, 2012. View at Publisher · View at Google Scholar
  • Otilia E. Frasinariu, Sara Ceccarelli, Anna Alisi, Evelina Moraru, and Valerio Nobili, “Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies,” Digestive and Liver Disease, 2012. View at Publisher · View at Google Scholar
  • Matthew T. Kitson, and Stuart K. Roberts, “D-livering the message: The importance of vitamin D status in chronic liver disease,” Journal Of Hepatology, vol. 57, no. 4, pp. 897–909, 2012. View at Publisher · View at Google Scholar
  • Kouichi Miura, and Hirohide Ohnishi, “Nonalcoholic fatty liver disease: From lipid profile to treatment,” Clinical Journal of Gastroenterology, vol. 5, no. 5, pp. 313–321, 2012. View at Publisher · View at Google Scholar
  • Pietro Vajro, Selvaggia Lenta, Claudio Pignata, Mariacarolina Salerno, Roberta D'Aniello, Ida De Micco, Giulia Paolella, and Giancarlo Parenti, “Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions,” Italian Journal Of Pediatrics, vol. 38, 2012. View at Publisher · View at Google Scholar
  • S. Berardis, and E. Sokal, “Pediatric non-alcoholic fatty liver disease: an increasing public health issue,” European Journal of Pediatrics, 2013. View at Publisher · View at Google Scholar
  • Giovanni Targher, Eleonora Scorletti, Alessandro Mantovani, and Christopher D. Byrne, “ Nonalcoholic Fatty Liver Disease and Reduced Serum Vitamin D 3 Levels ,” Metabolic Syndrome and Related Disorders, vol. 11, no. 4, pp. 217–228, 2013. View at Publisher · View at Google Scholar
  • Yoon Seok Roh, and Ekihiro Seki, “Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis,” Journal of Gastroenterology and Hepatology, vol. 28, pp. 38–42, 2013. View at Publisher · View at Google Scholar
  • Ryan M. Kwok, Dawn M. Torres, and Stephen A. Harrison, “Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association?,” Hepatology, 2013. View at Publisher · View at Google Scholar
  • Valerio Nobili, Pietro Vajro, Luca Miele, Gianluca Svegliati-Baroni, Luca Valenti, and Anna Alisi, “A 360-degree overview of paediatric NAFLD: Recent insights,” Journal Of Hepatology, vol. 58, no. 6, pp. 1218–1229, 2013. View at Publisher · View at Google Scholar
  • Wei Wang, Hongzhong Bi, Jin Pan, and Jian Ju, “Advances in study on role of intestinal microflora imbalance in the pathogenesis of non-alcoholic fatty liver disease,” Chinese Journal of Gastroenterology, vol. 18, no. 5, pp. 317–320, 2013. View at Publisher · View at Google Scholar
  • Yaron Ilan, “Immune Therapy for Nonalcoholic Steatohepatitis,” Journal of Clinical Gastroenterology, vol. 47, no. 4, pp. 298–307, 2013. View at Publisher · View at Google Scholar
  • Kouichi Miura, Ling Yang, Nico van Rooijen, David A. Brenner, Hirohide Ohnishi, and Ekihiro Seki, “Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice,” Hepatology, vol. 57, no. 2, pp. 577–589, 2013. View at Publisher · View at Google Scholar
  • Wei Zhang, Lu-wen Wang, Li-kun Wang, Xun Li, Hong Zhang, Li-Ping Luo, Jin-Chun Song, and Zuo-jiong Gong, “Betaine Protects Against High-Fat-Diet-Induced Liver Injury by Inhibition of High-Mobility Group Box 1 and Toll-Like Receptor 4 Expression in Rats,” Digestive Diseases and Sciences, vol. 58, no. 11, pp. 3198–3206, 2013. View at Publisher · View at Google Scholar
  • Jun Zhao, and Matthew W. Lawless, “Stop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer,” Cytokine, 2013. View at Publisher · View at Google Scholar
  • Anna Mae Diehl, John F. Rawls, and Jerome Boursier, “Obese Humans With Nonalcoholic Fatty Liver Disease Display Alterations in Fecal Microbiota and Volatile Organic Compounds,” Clinical Gastroenterology And Hepatology, vol. 11, no. 7, pp. 876–878, 2013. View at Publisher · View at Google Scholar
  • Jan Petrasek, Timea Csak, and Gyongyi Szabo, “Toll-Like Receptors in Liver Disease,” Advances in Clinical Chemistry, Vol 59, vol. 59, pp. 155–201, 2013. View at Publisher · View at Google Scholar
  • Yang Liu, Li Zhang, Haiyan Song, and Guang Ji, “Update on Berberine in Nonalcoholic Fatty Liver Disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, pp. 1–8, 2013. View at Publisher · View at Google Scholar
  • Antonella Scalera, Matteo Nicola Dario Di Minno, and Giovanni Tarantino, “What does irritable bowel syndrome share with non-alcoholic fatty liver disease?,” World Journal of Gastroenterology, vol. 19, no. 33, pp. 5402–5420, 2013. View at Publisher · View at Google Scholar
  • Claudia Della Corte, Daniela Liccardo, Federica Ferrari, Anna Alisi, and Valerio Nobili, “Current pharmacotherapy for treating pediatric nonalcoholic fatty liver disease,” Expert Opinion on Pharmacotherapy, pp. 1–11, 2014. View at Publisher · View at Google Scholar
  • E. B. Mitchel, and J. E. Lavine, “Review article: the management of paediatric nonalcoholic fatty liver disease,” Alimentary Pharmacology & Therapeutics, 2014. View at Publisher · View at Google Scholar
  • Gulsum Ozlem Elpek, “Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7260–7276, 2014. View at Publisher · View at Google Scholar
  • William Peverill, Lawrie W. Powell, and Richard Skoien, “Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation,” International Journal of Molecular Sciences, vol. 15, no. 5, pp. 8591–8638, 2014. View at Publisher · View at Google Scholar
  • Ajay Duseja, “Obesity and NAFLD The Role of Bacteria and Microbiota,” Clinics in Liver Disease, vol. 18, no. 1, pp. 59–+, 2014. View at Publisher · View at Google Scholar
  • Dongmin Li, Xuan Wang, Xi Lan, Yue Li, Li Liu, Jing Yi, Jing Li, Qingzhu Sun, Yili Wang, Hongmin Li, Nannan Zhong, Rikard Holmdahl, and Shemin Lu, “Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats,” Molecular and Cellular Endocrinology, 2014. View at Publisher · View at Google Scholar
  • Shayan Mohammadmoradi, Aida Javidan, and Javad Kordi, “Boom of probiotics: This time non-alcoholic fatty liver disease – A mini review,” Journal of Functional Foods, vol. 11, pp. 30–35, 2014. View at Publisher · View at Google Scholar
  • Giuseppina Mattace Raso, Raffaele Simeoli, Anna Iacono, Anna Santoro, Paola Amero, Orlando Paciello, Roberto Russo, Giuseppe D'Agostino, Margherita Di Costanzo, Roberto Berni Canani, Antonio Calignano, and Rosaria Meli, “Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet,” Journal of Nutritional Biochemistry, vol. 25, no. 1, pp. 81–90, 2014. View at Publisher · View at Google Scholar
  • Wei-Na Lu, and Li-Ying Feng, “Role of gut microbiota in pathogenesis of nonalcoholic fatty liver disease,” World Chinese Journal of Digestology, vol. 22, no. 3, pp. 340–344, 2014. View at Publisher · View at Google Scholar
  • Pierluigi Marzuillo, Emanuele Miragliadel Giudice, and Nicola Santoro, “Pediatric non-alcoholic fatty liver disease: New insights and future directions,” World Journal of Hepatology, vol. 6, no. 4, pp. 217–225, 2014. View at Publisher · View at Google Scholar
  • Xinwei Li, Weikun Huang, Jingmin Gu, Xiliang Du, Lin Lei, Xue Yuan, Guoquan Sun, Zhe Wang, Xiaobing Li, and Guowen Liu, “SREBP-1c overactivates ROS-mediated hepatic NF-κB inflammatory pathway in dairy cows with fatty liver,” Cellular Signalling, 2015. View at Publisher · View at Google Scholar
  • Feng Xiao, Shar L. Waldrop, Steve F. Bronk, Gregory J. Gores, Laurie S. Davis, and Gordan Kilic, “Lipoapoptosis induced by saturated free fatty acids stimulates monocyte migration: a novel role for Pannexin1 in liver cells,” Purinergic Signalling, 2015. View at Publisher · View at Google Scholar
  • Edmund Tse, Karla J. Helbig, Kylie Van der Hoek, Erin M. McCartney, Mark Van der Hoek, Jacob George, and Michael R. Beard, “Fatty Acids Induce a Pro-Inflammatory Gene Expression Profile in Huh-7 Cells That Attenuates the Anti-HCV Action of Interferon,” Journal Of Interferon And Cytokine Research, vol. 35, no. 5, pp. 392–400, 2015. View at Publisher · View at Google Scholar
  • Rui-Nan Zhang, Qin Pan, Zheng Zhang, Hai-Xia Cao, Feng Shen, and Jian-Gao Fan, “Saturated Fatty Acid Inhibits Viral Replication in Chronic Hepatitis B Virus Infection With Nonalcoholic Fatty Liver Disease by Toll-Like Receptor 4-Mediated Innate Immune Response,” Hepatitis Monthly, vol. 15, no. 5, 2015. View at Publisher · View at Google Scholar
  • Huiqun Tian, Chaoqi Liu, Xiaohua Zou, Wei Wu, Changcheng Zhang, and Ding Yuan, “MiRNA-194 Regulates Palmitic Acid-Induced Toll-Like Receptor 4 Inflammatory Responses in THP-1 Cells,” Nutrients, vol. 7, no. 5, pp. 3483–3496, 2015. View at Publisher · View at Google Scholar
  • S. A. AlKhater, “Paediatric non-alcoholic fatty liver disease: an overview,” Obesity Reviews, 2015. View at Publisher · View at Google Scholar
  • Luisina I. Onofrio, Alfredo R. Arocena, Augusto F. Paroli, Maria E. Cabalen, Marta C. Andrada, Roxana C. Cano, and Susana Gea, “Trypanosoma cruzi Infection Is a Potent Risk Factor for Non-alcoholic Steatohepatitis Enhancing Local and Systemic Inflammation Associated with Strong,” Plos Neglected Tropical Diseases, vol. 9, no. 2, 2015. View at Publisher · View at Google Scholar
  • Mohamed Asrih, and François R. Jornayvaz, “Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?,” Molecular and Cellular Endocrinology, 2015. View at Publisher · View at Google Scholar
  • Myrto Eliades, and Elias Spyrou, “Vitamin D: a new player in non-alcoholic fatty liver disease?,” World Journal Of Gastroenterology, vol. 21, no. 6, pp. 1718–1727, 2015. View at Publisher · View at Google Scholar
  • Pierluigi Ramadori, Daniela Kroy, and Konrad L Streetz, “Immunoregulation by lipids during the development of non-alcoholic steatohepatitis.,” Hepatobiliary surgery and nutrition, vol. 4, no. 1, pp. 11–23, 2015. View at Publisher · View at Google Scholar
  • Pushpjeet Kanwar, and Kris V. Kowdley, “The Metabolic Syndrome and Its Influence on Nonalcoholic Steatohepatitis,” Clinics in Liver Disease, 2015. View at Publisher · View at Google Scholar
  • Agnieszka Zwolak, Agnieszka Szuster-Ciesielska, Jadwiga Daniluk, Olga Slabczynska, and Martyna Kandefer-Szerszen, “Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine b,” Plos One, vol. 10, no. 12, 2015. View at Publisher · View at Google Scholar
  • Laura Marino, and Francois R. Jornayvaz, “Endocrine causes of nonalcoholic fatty liver disease,” World Journal Of Gastroenterology, vol. 21, no. 39, pp. 11053–11076, 2015. View at Publisher · View at Google Scholar
  • Mazen Noureddin, David Alexanian, and Neil Kaplowitzpp. 149–173, 2015. View at Publisher · View at Google Scholar
  • Pei Lin, Jianmei Lu, Yanfang Wang, Wen Gu, Jie Yu, and Ronghua Zhao, “Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis.,” PloS one, vol. 10, no. 10, 2015. View at Publisher · View at Google Scholar
  • Xin Dai, and Bangmao Wang, “Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease,” Gastroenterology Research and Practice, vol. 2015, pp. 1–6, 2015. View at Publisher · View at Google Scholar
  • Sara Ceccarelli, Laura Agostinelli, Laura Stronati, Salvatore Cucchiara, Giovanni Musso, Cesare Furlanello, Gianluca Svegliati-Baroni, Valerio Nobili, Anna Alisi, Nadia Panera, Marco Mina, Daniela Gnani, Cristiano De Stefanis, Annalisa Crudele, Chiara Rychlicki, Stefania Petrini, and Giovannella Bruscalupi, “LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease,” Oncotarget, vol. 6, no. 39, pp. 41434–41452, 2015. View at Publisher · View at Google Scholar
  • Fuyuan Yan, Xiaoqing Wang, Jian Ju, and Fan Gao, “Effect of total saponins of radix clematidis on serum IL-6, IL-17, TNF-α and liver pathology in experimental NASH rats,” Chinese Journal of Gastroenterology, vol. 21, no. 9, pp. 523–527, 2016. View at Publisher · View at Google Scholar
  • Mazen Noureddin, Alice Zhang, and Rohit Loomba, “Promising therapies for treatment of nonalcoholic steatohepatitis,” Expert Opinion on Emerging Drugs, pp. 1–15, 2016. View at Publisher · View at Google Scholar
  • Nadine Gehrke, Marcus A. Wörns, Yvonne Huber, Moritz Hess, Beate K. Straub, Nadine Hövelmeyer, Ari Waisman, Yong Ook Kim, Detlef Schuppan, Peter R. Galle, and Jörn M. Schattenberg, “Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors,” Journal of Hepatology, 2016. View at Publisher · View at Google Scholar
  • Nishika Sahini, and Jürgen Borlak, “Genomics of human fatty liver disease reveal mechanistically linked lipid droplet associated gene regulations in blunt steatosis and NASH,” Translational Research, 2016. View at Publisher · View at Google Scholar
  • Kouichi Miura, and Hirohide Ohnishi, “Innate Immunity and the Liver,” The Liver in Systemic Diseases, pp. 3–24, 2016. View at Publisher · View at Google Scholar
  • M. Noureddin, Q. M. Anstee, and R. Loomba, “Review: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis,” Alimentary Pharmacology & Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Eveliina Munukka, Petri Wiklund, Tiina Partanen, Sakari Valimaki, Eija K. Laakkonen, Maarit Lehti, Pamela Fischer-Posovzsky, Martin Wabitsch, Sulin Cheng, Pentti Huovinen, and Satu Pekkala, “Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation,” Plos One, vol. 11, no. 4, 2016. View at Publisher · View at Google Scholar
  • Hakan Fotbolcu, and Elcin Zorlu, “Nonalcoholic fatty liver disease as a multi-systemic disease,” World Journal Of Gastroenterology, vol. 22, no. 16, pp. 4079–4090, 2016. View at Publisher · View at Google Scholar
  • Agnieszka Zwolak, Olga Slabczynska, Justyna Semeniuk, Jadwiga Daniluk, and Agnieszka Szuster-Ciesielska, “Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies,” Plos One, vol. 11, no. 3, 2016. View at Publisher · View at Google Scholar
  • Helena Cortez-Pinto, Paula Borralho, Jorge Machado, Maria T. Lopes, Inês V. Gato, António M. Santos, and António S. Guerreiro, “Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH),” GE Portuguese Journal of Gastroenterology, 2016. View at Publisher · View at Google Scholar
  • Griselda M. Rabadán-Chávez, Angel Miliar Garcia, Norma Paniagua Castro, Gerardo Escalona Cardoso, Lucia Quevedo-Corona, Elba Reyes-Maldonado, and María Eugenia Jaramillo-Flores, “Modulating the expression of genes associated with hepatic lipid metabolism, lipoperoxidation and inflammation by cocoa, cocoa extract and cocoa flavanols related to hepatic steatosis induced by a hypercaloric diet,” Food Research International, 2016. View at Publisher · View at Google Scholar
  • Yueli Tian, Wudong Wang, Jia Xu, Jingting Ma, Lingjuan Zhang, Kai Wang, and Dongfu Li, “Resveratrol supplement inhibited the NF-κB inflammation pathway through activating AMPKα-SIRT1 pathway in mice with fatty liver,” Molecular and Cellular Biochemistry, vol. 422, no. 1-2, pp. 75–84, 2016. View at Publisher · View at Google Scholar
  • Hu Xiao, Naoki Tanaka, Guo Ran, Lu Yu, Takero Nakajima, Frank J. Gonzalez, and Toshifumi Aoyama, “PPARα protects against trans-fatty acid-containing diet-induced steatohepatitis,” The Journal of Nutritional Biochemistry, 2016. View at Publisher · View at Google Scholar
  • Yu-Feng Liu, Jian-Yang Wei, Mao-Hua Shi, Hua Jiang, and Jie Zhou, “Glucocorticoid induces hepatic steatosis by inhibiting activating transcription factor 3 (ATF3)/S100A9 protein signaling in granulocytic myeloid-derived suppressor cells,” Journal of Biological Chemistry, vol. 291, no. 41, pp. 21771–21785, 2016. View at Publisher · View at Google Scholar
  • Stephanie R. Wesolowski, Karim C. El Kasmi, Karen R. Jonscher, and Jacob E. Friedman, “Developmental origins of NAFLD: a womb with a clue,” Nature Reviews Gastroenterology & Hepatology, 2016. View at Publisher · View at Google Scholar
  • Hirofumi Okubo, Akifumi Kushiyama, Hideyuki Sakoda, Yusuke Nakatsu, Masaki Iizuka, Naoyuki Taki, Midori Fujishiro, Toshiaki Fukushima, Hideaki Kamata, Akiko Nagamachi, Toshiya Inaba, Fusanori Nishimura, Hideki Katagiri, Takashi Asahara, Yasuto Yoshida, Osamu Chonan, Jeffery Encinas, and Tomoichiro Asano, “Involvement of resistin-like molecule β in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice,” Scientific Reports, vol. 6, pp. 20157, 2016. View at Publisher · View at Google Scholar
  • N. Matsushita, T. Osaka, I. Haruta, H. Ueshiba, N. Yanagisawa, M. Omori-Miyake, E. Hashimoto, N. Shibata, K. Tokushige, K. Saito, S. Tsuneda, and J. Yagi, “Effect of Lipopolysaccharide on the Progression of Non-Alcoholic Fatty Liver Disease in High Caloric Diet-Fed Mice,” Scandinavian Journal of Immunology, vol. 83, no. 2, pp. 109–118, 2016. View at Publisher · View at Google Scholar
  • Ju Ri Ham, Hae-In Lee, Ra-Yeong Choi, Mi-Ok Sim, Kwon-Il Seo, and Mi-Kyung Lee, “Anti-steatotic and anti-inflammatory roles of syringic acid in high-fat diet-induced obese mice,” Food Funct., vol. 7, no. 2, pp. 689–697, 2016. View at Publisher · View at Google Scholar
  • Xingyong Wan, Chengfu Xu, Chaohui Yu, and Youming Li, “Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH,” Canadian Journal of Gastroenterology and Hepatology, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Sena Bluemel, Bernd Schnabl, Brandon Williams, and Rob Knight, “Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota,” American Journal of Physiology - Gastrointestinal and Liver Physiology, vol. 311, no. 6, pp. G1018–G1036, 2016. View at Publisher · View at Google Scholar
  • Safak Kiziltas, “Toll-like receptors in pathophysiology of liver diseases,” World Journal of Hepatology, vol. 8, no. 32, pp. 1354–1369, 2016. View at Publisher · View at Google Scholar
  • Andrew A. Pierce, Caroline C. Duwaerts, Kevin Siao, Aras N. Mattis, Amanda Goodsell, Jody L. Baron, and Jacquelyn J. Maher, “CD18 deficiency improves liver injury in the MCD model of steatohepatitis,” Plos One, vol. 12, no. 9, pp. e0183912, 2017. View at Publisher · View at Google Scholar
  • Savinda Liyanagedera, Robert Patrick Williams, Silvio Veraldi, Valerio Nobili, and Jake P. Mann, “The pharmacological management of NAFLD in children and adolescents,” Expert Review of Clinical Pharmacology, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  • Peizhi Li, Kun He, Jinzheng Li, Zuojin Liu, and Jianping Gong, “The role of Kupffer cells in hepatic diseases,” Molecular Immunology, vol. 85, pp. 222–229, 2017. View at Publisher · View at Google Scholar
  • Thibaut Duparc, Fredrik Bäckhed, Daniel Monleon, Amandine Everard, Patrice D. Cani, Hubert Plovier, Vannina G. Marrachelli, Matthias Van Hul, Ahmed Essaghir, Marcus Ståhlman, Sébastien Matamoros, Lucie Geurts, Mercedes M. Pardo-Tendero, Céline Druart, Nathalie M. Delzenne, Jean-Baptiste Demoulin, Schalk W. Van Der Merwe, and Jos Van Pelt, “Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism,” Gut, vol. 66, no. 4, pp. 620–632, 2017. View at Publisher · View at Google Scholar
  • Yumi Kishida, Hirofumi Okubo, Haruya Ohno, Kenji Oki, and Masayasu Yoneda, “Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model,” Journal of Gastroenterology, 2017. View at Publisher · View at Google Scholar
  • Ming Zhang, Yujie Zhao, Zhen Li, and Congying Wang, “Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis,” Biochemical and Biophysical Research Communications, 2017. View at Publisher · View at Google Scholar
  • Melanie Tran, Sang-Min Lee, Dong-Ju Shin, and Li Wang, “Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH,” JCI Insight, vol. 2, no. 21, 2017. View at Publisher · View at Google Scholar
  • Lixin Xu, Lijun Yan, and Weiwei Tao, “Pilose antler peptide attenuates high-fat-diet-induced liver injury,” Toxicology Mechanisms and Methods, pp. 1–7, 2017. View at Publisher · View at Google Scholar
  • Xiao-Lin Liu, Ya-Nan Ming, Jing-Yi Zhang, Xiao-Yu Chen, Min-De Zeng, and Yi-Min Mao, “Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes,” Experimental & Molecular Medicine, vol. 49, no. 1, pp. e283, 2017. View at Publisher · View at Google Scholar
  • Shanhong Lu, Ting Zhang, Wen Gu, Xingxin Yang, Jianmei Lu, Ronghua Zhao, and Jie Yu, “ Volatile Oil of Amomum villosum Inhibits Nonalcoholic Fatty Liver Disease via the Gut-Liver Axis ,” BioMed Research International, vol. 2018, pp. 1–16, 2018. View at Publisher · View at Google Scholar
  • Yupei Zhang, Kairui Tang, Yuanjun Deng, Runsen Chen, Shu Liang, Huijun Xie, Yifang He, Yanning Chen, and Qinhe Yang, “Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats,” Biomedicine & Pharmacotherapy, vol. 102, pp. 1025–1036, 2018. View at Publisher · View at Google Scholar
  • Yosuke Osawa, Ekumi Kojika, Yukiko Hayashi, Masamichi Kimura, Koji Nishikawa, Sachiyo Yoshio, Hiroyoshi Doi, Tatsuya Kanto, and Kiminori Kimura, “Tumor necrosis factor-α-mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice,” Hepatology Communications, 2018. View at Publisher · View at Google Scholar
  • Jana Hundertmark, Oliver Krenkel, and Frank Tacke, “Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease,” Frontiers in Immunology, vol. 9, 2018. View at Publisher · View at Google Scholar
  • Peng Huang, Benson Kaluba, Xiao-lin Jiang, Shi Chang, Xiao-feng Tang, Lin-feng Mao, Zhi-peng Zhang, and Fei-zhou Huang, “Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis,” BioMed Research International, vol. 2018, pp. 1–7, 2018. View at Publisher · View at Google Scholar
  • Stefano Bibbò, Gianluca Ianiro, Maria Pina Dore, Claudia Simonelli, Estelle E. Newton, and Giovanni Cammarota, “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease,” Mediators of Inflammation, vol. 2018, pp. 1–7, 2018. View at Publisher · View at Google Scholar